Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing
about
Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patientsMolecular alterations and biomarkers in colorectal cancerValidation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validationRole of Deficient Mismatch Repair in the Personalized Management of Colorectal CancerHereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening.Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based studyScreening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.Colorectal cancer molecular biology moves into clinical practice.Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats.Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry.ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.Improved testing for microsatellite instability in colorectal cancer using a simplified 3-marker assay.Improved Detection of Microsatellite Instability in Early Colorectal Lesions.Influence of patient preferences on the cost-effectiveness of screening for lynch syndromeMolecular signaling mechanisms of apoptosis in hereditary non-polyposis colorectal cancerProficiency of DNA repair genes and microsatellite instability in operated colorectal cancer patients with clinical suspicion of lynch syndrome.Rad9 plays an important role in DNA mismatch repair through physical interaction with MLH1Predictive and prognostic factors in colorectal cancer: a personalized approach.Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiency.Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry.The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry.Lynch syndrome diagnostics: decision-making process for germ-line testing.The utility of immunohistochemistry for providing genetic information on tumors.Evaluation of colorectal cancers for Lynch syndrome: practical molecular diagnostics for surgical pathologists.Mismatch repair deficiency testing in clinical practice.Mismatch Repair Deficiency and Response to Immune Checkpoint BlockadeColorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.Can Microsatellite Status of Colorectal Cancer Be Reliably Assessed after Neoadjuvant Therapy?Current and future biomarkers in colorectal cancer.Microsatellite instability testing in Korean patients with colorectal cancer.No microsatellite instability using Bethesda panel and revised markers in uterine leiomyomas.Current Lynch syndrome tumor screening practices: a survey of genetic counselors.Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome-associated Endometrial Cancer.Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients.Mismatch repair enzyme expression in primary and castrate resistant prostate cancer.Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer.Genetic testing for Lynch syndrome in the province of Ontario.
P2860
Q21328691-A01C3DAD-9FBC-4F69-B612-21C6F470E7BBQ26862317-80520222-B72A-4548-95C4-753790CBC7C5Q28075719-7E5C4CD6-78D4-4C9E-AC02-F2AB7C65A9EDQ28080176-9EE46A3B-FEC7-4361-9F89-519D8A93AB19Q28085485-AD9FEB67-1A40-4B27-9C19-92B3BC7F4858Q33653935-A87BB5CC-70D3-4EAD-BC1A-E0BD686A6997Q33658603-C74A0AD3-0450-4C2D-86FF-73837400F784Q33775296-4492CF9F-2FCB-4D87-A4C5-D71216DFE502Q34425013-D7A2F0DE-2622-477B-8533-1948CB04643BQ34433799-5C67D056-C796-4DC6-8AF9-8B32FB852F0AQ34801092-BE850F51-686C-4D51-BF4F-1D2F8150ABB4Q35078072-4F10D077-9C06-4A67-A2F2-0CA4B4DEFFD5Q35720171-6F9764B5-5064-40E3-9692-F5E535857765Q35739815-ABFDFA7D-0762-43A9-87EF-A41175AD678CQ35947752-78780FBE-5AD3-472A-A4F7-F3F700515B5AQ36057058-75EE6426-D47A-497D-B113-C3B7C98F456FQ36352432-B33A67AB-2DBD-47D0-9986-D82FF2E8991DQ36972154-F05404CA-D51D-428F-93C5-BD8397348699Q37132653-4D0A72DA-0D3C-48A9-9E8F-831147B4D332Q37221791-41E955E5-B64E-41FB-B7ED-27477A9E1EEFQ37221983-B38A4A1A-643E-45BA-BA56-CBA597FC4EE9Q37710549-8ADB1905-E46F-4BB2-9032-A685E0A7CFA0Q37733942-CB0DAAC2-946D-4065-B3B3-D71C3C45B84BQ38000941-D90D3E29-50E6-462C-87BB-A8026523ED2BQ38142818-873973FA-3420-44CF-99D2-633A16DE316AQ38308050-1B92C9ED-FA0D-4105-82E7-34BC8BC793C4Q38741029-946E7D5E-4250-4510-979E-12E61320DD4EQ38895750-37AB178F-8A9A-414E-9014-3E2EE1C63533Q39334444-F2DC20FD-BD9F-49C5-8437-322C8507EF51Q40195853-5EA39AE3-ACB9-4D32-9F0C-69858616B450Q43492228-AEE673E3-D337-49CD-83E7-8AF21A5CCB85Q44003216-2BFFB909-F1CF-4B63-B96E-86FE26D044AEQ44355083-F33B5356-46C2-4465-A9F7-57A92303DF48Q45898127-4E6E8007-0B9C-420C-A0C5-B60E1C010910Q47713578-D99CA1B6-4A19-4C34-9720-F867F335258EQ47935364-7F44F291-4D48-4D3D-A370-DA0F52D457D7Q50049563-06C07E66-7A99-456A-9C80-83AFF637DD63Q51789451-F9C15B2B-B001-48DC-BE37-ADADD20BC745Q52659178-BA90ED94-A53A-442A-A044-D2F2309ABFEAQ53137270-F3D01E1B-F62C-4E70-98DB-196495514BC4
P2860
Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Immunohistochemistry versus mi ...... osatellite instability testing
@ast
Immunohistochemistry versus mi ...... osatellite instability testing
@en
type
label
Immunohistochemistry versus mi ...... osatellite instability testing
@ast
Immunohistochemistry versus mi ...... osatellite instability testing
@en
prefLabel
Immunohistochemistry versus mi ...... osatellite instability testing
@ast
Immunohistochemistry versus mi ...... osatellite instability testing
@en
P2860
P921
P1476
Immunohistochemistry versus mi ...... osatellite instability testing
@en
P2093
Liying Zhang
P2860
P304
P356
10.2353/JMOLDX.2008.080062
P577
2008-06-13T00:00:00Z